We are committed to developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with serious and life-threatening conditions. Basilea is located in the Basel area, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN).
CEO David Veitch | Half-Year Report 2024
Play
News
Aug 27. 2024
/ Ad hoc announcement
Aug 21. 2024
Aug 13. 2024
/ Ad hoc announcement
Half-Year Report 2024
CEO Statement
For the benefit of patients around the world, we are continuing to establish Cresemba and Zevtera as truly global brands. Based on our proven expertise in advancing anti-infectives through research and development to the market, we are aiming at becoming one of the leading companies in this space.
![](/fileadmin/basilea.com/redaktion/hero/_HOME_Portrait_David-Veitch.jpg?v=1669643545)